What to Expect in the Week Ahead (GS, JNJ, TSM, and NFLX Earnings; Retail Sales and Housing Starts)
Earnings in the week ahead could be the next catalyst for a broadening market
Eli Lilly's GLP-1 Impact on ResMed Is Overblown: Barron's
Morgan Stanley Sees $180B Patent Cliff, $380B Deal Capacity Fueling Biopharma M&A
Financial Stocks Deliver Profits in Q2 Amid Rebound in Investments - Earnings Scorecard
Lilly Expecting Q2 IPR&D Pre-tax Charge of Around $0.14 per Share: Report
These Are the Stocks With the Highest Increase in Short Interest Within Life Sciences and Diagnostics - Baird
Looking At Thermo Fisher Scientific's Recent Unusual Options Activity
Financial giants have made a conspicuous bearish move on Thermo Fisher Scientific. Our analysis of options history for Thermo Fisher Scientific (NYSE:TMO) revealed 9 unusual trades.Delving into the
Merck's Acquisition of EyeBio Finalized
Merck (NYSE:MRK) is trending on Friday. The company announced the acquisition of EyeBio, introducing a novel candidate to Merk's pipeline, Restoret.What To Know: Restoret has shown promising results
With Oral Anti-Obesity Candidate Development, Pfizer Seeks Relevant And Competitive Presence - Goldman Sachs
Thursday, Pfizer Inc (NYSE:PFE) announced it selected its preferred once-daily modified release formulation for danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist.Pfizer plans to
Executive Reshuffles: ChargePoint, Tupperware and ADM in Focus
In-Depth Analysis: Eli Lilly and Co Versus Competitors In Pharmaceuticals Industry
In today's rapidly changing and fiercely competitive business landscape, it is vital for investors and industry enthusiasts to carefully evaluate companies. In this article, we will perform a
These Are the Weight Loss Drug Stocks With the Most Upside - SA Sentiment Survey
Novo's Ozempic Linked to Improved Brain Health: Study
Using Ozempic, Zepbound Or Other Weight Loss Drugs? Inform Doctors Before Anesthesia Or Surgery, European Medicines Agency Issues Advisory
On Friday, the European Medicines Agency (EMA) warned patients using weight-loss drugs, such as Novo Nordisk A/S's (NYSE:NVO) Wegovy, to inform their doctors before general anesthesia or deep
Dividend Roundup: Procter & Gamble, Costco, CVS Health, Colgate-Palmolive, and More
Australia Based Cancer Focused Immutep's Lead Cancer Drug Shows 'Meaningful Response' In Untreated Head & Neck Cancer, Stock Soars
Friday, Immutep Limited (NASDAQ:IMMP) released results from Cohort B of the TACTI-003 (KEYNOTE-PNC-34) Phase 2b trial of eftilagimod alfa (efti) in combination with Merck & Co Inc (NYSE:MRK) Keytruda (pembrolizumab) as first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma patients with negative PD-L1 expression.
This Weight Loss Stock Is the Best Alternative to Eli Lilly, Novo - SA Sentiment
Eli Lilly, Novo Nordisk Shares Dip as Pfizer Ramps Up Diabetes Drug Competition
Shares of $Eli Lilly and Co(LLY.US)$ and $Novo-Nordisk A/S(NVO.US)$ finished lower on Thursday, perhaps influenced by competitive developments and regulatory updates in the pharmaceutical sector.
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical
AbbVie Unusual Options Activity
Investors with a lot of money to spend have taken a bearish stance on AbbVie (NYSE:ABBV).And retail traders should know.We noticed this today when the positions showed up on publicly available